These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 37482730

  • 21. Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Chen H, Zhu L, Zhuang Y, Ye X, Chen F, Zeng J.
    Cancer Control; 2024; 31():10732748241295347. PubMed ID: 39425895
    [Abstract] [Full Text] [Related]

  • 22. Risk factors for posterior to right recurrent laryngeal nerve lymph node metastasis in papillary thyroid carcinoma.
    Zhang DG, Gao L, Miao YW, He GF, Xie L.
    Saudi Med J; 2014 Aug; 35(8):832-7. PubMed ID: 25129182
    [Abstract] [Full Text] [Related]

  • 23. Clinical value and indication for the dissection of lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma.
    Luo DC, Xu XC, Ding JW, Zhang Y, Peng Y, Pan G, Zhang W.
    Oncotarget; 2017 Oct 03; 8(45):79897-79905. PubMed ID: 29108371
    [Abstract] [Full Text] [Related]

  • 24. A Comparison of Two Operation Methods Revealed the Risk Factors and the Necessity of LN-prRLN Dissection in Papillary Thyroid Carcinoma: A Retrospective Cohort Study in FUSCC.
    Wang Y, Wang D, Chen L, Guo K, Sun T.
    Int J Endocrinol; 2020 Oct 03; 2020():7162793. PubMed ID: 32963525
    [Abstract] [Full Text] [Related]

  • 25. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
    Chang Q, Zhang J, Wang Y, Li H, Du X, Zuo D, Yin D.
    Front Endocrinol (Lausanne); 2022 Oct 03; 13():937049. PubMed ID: 35909521
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Model of lymph node metastasis posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma.
    Luo Y, Xu XC, Shen J, Shi JJ, Lu S, He W, Lei JY, Luo DC.
    Cancer Manag Res; 2018 Oct 03; 10():2449-2455. PubMed ID: 30122994
    [Abstract] [Full Text] [Related]

  • 29. Preoperative Prediction of Metastatic Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in cN0 Papillary Thyroid Carcinoma.
    Shao J, Wang X, Yu H, Ding W, Xu B, Ma D, Huang X, Yin H.
    Cancer Manag Res; 2024 Oct 03; 16():421-429. PubMed ID: 38736588
    [Abstract] [Full Text] [Related]

  • 30. Unnecessity of Routine Dissection of Right Central Lymph Nodes in cN0 Papillary Thyroid Carcinoma Located at the Left Thyroid Lobe.
    Zhang S, Zhang R, Wang C, Gong W, Zheng C, Fang Q, Dai L.
    Front Oncol; 2021 Oct 03; 11():685708. PubMed ID: 34277432
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cervical lymph node metastasis prediction of postoperative papillary thyroid carcinoma before 131I therapy based on clinical and ultrasound characteristics.
    Yu F, Wu W, Zhang L, Li S, Yao X, Wang J, Ni Y, Meng Q, Yang R, Wang F, Shi L.
    Front Endocrinol (Lausanne); 2023 Oct 03; 14():1122517. PubMed ID: 36875475
    [Abstract] [Full Text] [Related]

  • 34. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.
    Li J, Sun P, Huang T, Li L, He S, Ai X, Xiao H, Xue G.
    Eur J Surg Oncol; 2022 Jun 03; 48(6):1272-1279. PubMed ID: 35414404
    [Abstract] [Full Text] [Related]

  • 35. [Risk factors analysis and prediction model establishment of contralateral central lymph node metastasis in intermediate-to-high risk unilateral papillary thyroid carcinoma].
    Wang SS, Miao SC, Shan JL, Zhang D, Wang QQ, Ni QC, Fang J.
    Zhonghua Yi Xue Za Zhi; 2024 Sep 24; 104(36):3416-3421. PubMed ID: 39307716
    [Abstract] [Full Text] [Related]

  • 36. Single-center external validation and reconstruction of multiple predictive models for skip lateral lymph node metastasis in papillary thyroid carcinoma.
    Li Q, Huang C, Zou H, Zhang J, Xin J.
    Front Endocrinol (Lausanne); 2024 Sep 24; 15():1366679. PubMed ID: 39319253
    [Abstract] [Full Text] [Related]

  • 37. A radiomics nomogram for the ultrasound-based evaluation of central cervical lymph node metastasis in papillary thyroid carcinoma.
    Wen Q, Wang Z, Traverso A, Liu Y, Xu R, Feng Y, Qian L.
    Front Endocrinol (Lausanne); 2022 Sep 24; 13():1064434. PubMed ID: 36531493
    [Abstract] [Full Text] [Related]

  • 38. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma.
    Zhang L, Liu H, Xie Y, Xia Y, Zhang B, Shan G, Li X.
    Eur J Surg Oncol; 2016 Jan 24; 42(1):81-6. PubMed ID: 26615455
    [Abstract] [Full Text] [Related]

  • 39. A Nomogram Based on Clinical and Ultrasound Characteristics to Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Feng JW, Hong LZ, Wang F, Wu WX, Hu J, Liu SY, Jiang Y, Ye J.
    Front Endocrinol (Lausanne); 2021 Jan 24; 12():666315. PubMed ID: 33995284
    [Abstract] [Full Text] [Related]

  • 40. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
    Feng Y, Min Y, Chen H, Xiang K, Wang X, Yin G.
    J Endocrinol Invest; 2021 Oct 24; 44(10):2203-2211. PubMed ID: 33586026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.